Allmed Solutions Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

-34.08%

Rev. gr., 5y

16.57%

Revenues

Net income

-14m

L+161,280.26%

CFO

-12m

L+50.55%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Based in Caesarea, Israel, Allium Medical Solutions Ltd. specializes in the creation, manufacturing, and global distribution of advanced, long-term medical stents. These innovative devices are fully covered, designed for expansion, and are retrievable, serving to alleviate various obstructions within the urinary and gastrointestinal (GI) tracts. Their product portfolio encompasses a range of specialized stents, including those for ureteric, bulbar, triangular and round prostatic, and biliary applications.

Key people

Shai Tag

Finance Director · since 2019

Shay Arotchas

Vice President - Operations · since 2013

Ehud Geller

Director · since 2012

Jacob Dagan

Independent Director · since 2016

URL

https://www.allium-medical.com/

IPO date

Feb 01, 2007

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title ILS in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title ILS in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT